UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

(Amendment No. )*



Viveon Health Acquisition Corp.

(Name of Issuer)

 

Common stock, par value $0.0001 per share

(Title of Class of Securities)

 

92853V106

(CUSIP Number)

 

 

December 31, 2022
(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

x Rule 13d-1(b)

o Rule 13d-1(c)

o Rule 13d-1(d)

 

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 


 

CUSIP No.  92853V106
 SCHEDULE 13G
Page 2 of 6 Pages

 

         
1
NAME OF REPORTING PERSONS
 
Fir Tree Capital Management LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
 
3
SEC USE ONLY
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
 
518,742
6
SHARED VOTING POWER
 
0
7
SOLE DISPOSITIVE POWER
 
518,742
8
SHARED DISPOSITIVE POWER
 
0
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
518,742
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 
 
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
5.15%
12
TYPE OF REPORTING PERSON
 
IA

 


 

 

CUSIP No. 92853V106
 SCHEDULE 13G
Page 3 of 6 Pages

 

Item 1.(a) Name of Issuer

Viveon Health Acquisition Corp.

Item 1.(b) Address of Issuer’s Principal Executive Offices

c/o Gibson, Deal & Fletcher, PC

Spalding Exchange

3953 Holcomb Bridge Road, Suite 200

Norcross, GA 30092

Item 2.(a, b, c) Names of Person Filing, Address of Principal Business Office, Citizenship:

Fir Tree Capital Management LP a Delaware limited partnership, located at 500 5th Avenue, 9th Floor, New York, New York 10110

  

Item 2.(d) Title of Class of Securities

Common stock, par value $0.0001 per share (the “Common Stock”)

 

Item 2.(e) CUSIP No.:

92853V106

 

CUSIP No.  92853V106
 SCHEDULE 13G
Page 4 of 6 Pages

 

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

  (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
 
  (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
 
  (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
 
  (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
 
  (e) x An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
 
  (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
 
  (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
 
  (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
 
  (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
 
  (j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
 
  (k) ¨ A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:                            
       

 

CUSIP No. 92853V106
 SCHEDULE 13G
Page 5 of 6 Pages

 

 

Item 4. Ownership

Information with respect to the Reporting Person’s ownership of the Common Stock as of December 31, 2022, is incorporated by reference to items (5) - (9) and (11) of the cover page for the Reporting Person.

The amount beneficially owned by the Reporting Person is determined based on 10,064,124 shares of Common Stock outstanding as of November 18, 2022 , as the Issuer reported in its Form 10-Q filed with the SEC on November 21, 2022.

Item 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

Item 6. Ownership of More Than Five Percent on Behalf of Another Person

Not Applicable.

Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

Not Applicable.

Item 8. Identification and Classification of Members of the Group

Not Applicable.

Item 9. Notice of Dissolution of Group 

Not Applicable.

Item 10. Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 
CUSIP No. 92853V106
 SCHEDULE 13G
Page 6 of 6 Pages

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 14, 2023

 

 

 

 

Fir Tree Capital Management LP

       
  By:  /s/ Brian Meyer
    Brian Meyer, General Counsel
       
       

Viveon Health Acquisition (AMEX:VHAQ)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Viveon Health Acquisition.
Viveon Health Acquisition (AMEX:VHAQ)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Viveon Health Acquisition.

Notícias Viveon Health Acquisition Corp.

Tech Centric Healthcare Services Company Continues To Move Forward With Its Business Combination and Exchange Listing
Segunda, 22 de Julho de 2024 (5 meses atrás) • GlobeNewswire Inc.
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Quinta, 6 de Junho de 2024 (7 meses atrás) • Edgar (US Regulatory)
Form 425 - Prospectuses and communications, business combinations
Quarta, 5 de Junho de 2024 (7 meses atrás) • Edgar (US Regulatory)
Form 8-K - Current report
Quarta, 5 de Junho de 2024 (7 meses atrás) • Edgar (US Regulatory)
Clearday Announces Board Resignation of Jeff Coleman with Warm Wishes for His Future Success - Updated
Sexta, 3 de Maio de 2024 (8 meses atrás) • GlobeNewswire Inc.
Clearday Announces Board Resignation of Jeff Coleman with Warm Wishes for His Future Success
Quinta, 2 de Maio de 2024 (8 meses atrás) • GlobeNewswire Inc.
Form 425 - Prospectuses and communications, business combinations
Segunda, 1 de Abril de 2024 (9 meses atrás) • Edgar (US Regulatory)
Form 8-K - Current report
Segunda, 1 de Abril de 2024 (9 meses atrás) • Edgar (US Regulatory)
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Sexta, 29 de Março de 2024 (9 meses atrás) • Edgar (US Regulatory)
Form 425 - Prospectuses and communications, business combinations
Quarta, 27 de Março de 2024 (9 meses atrás) • Edgar (US Regulatory)
Form 8-K - Current report
Quarta, 27 de Março de 2024 (9 meses atrás) • Edgar (US Regulatory)
Form DEF 14A - Other definitive proxy statements
Sexta, 1 de Março de 2024 (10 meses atrás) • Edgar (US Regulatory)

Mais Notícias de Viveon Health Acquisition Corp.